Spyre
SYRESpyre Therapeutics, Inc. Price (SYRE)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
374,387,000
(5000.427)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Spyre Therapeutics, Inc.Currency: USD
| YEAR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
0.00
+0% |
6,085,000.00
+0% |
4,628,000.00
-24% |
5,205,000.00
+12% |
3,888,000.00
-25% |
0.00
+0% |
0.00
+0% |
18,739,000.00
+0% |
2,329,000.00
-88% |
886,000.00
-62% |
0.00
+0% |
||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 19,000.00 | 89,000.00 | 0.00 | 0.00 | 0.00 | 901,000.00 | 1,624,000.00 | 2,001,000.00 | 1,964,000.00 | 964,000.00 | 0.00 | ||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
-19,000.00
+0% |
5,996,000.00
-31,658% |
4,628,000.00
-23% |
5,205,000.00
+12% |
3,888,000.00
-25% |
-901,000.00
-123% |
-1,624,000.00
+80% |
16,738,000.00
-1,131% |
365,000.00
-98% |
-78,000.00
-121% |
0.00
+0% |
||||||||
| Gross Profit Ratio | (0.00%) | (0.99%) | (1.00%) | (1.00%) | (1.00%) | (0.00%) | (0.00%) | (0.89%) | (0.16%) | (-0.09%) | (0.00%) | ||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 6,830,000.00 | 11,453,000.00 | 18,143,000.00 | 22,815,000.00 | 36,719,000.00 | 64,599,999.00 | 59,638,000.00 | 57,069,000.00 | 58,579,000.00 | 89,504,000.00 | 162,790,000.00 | ||||||||
| General and Administrative | 0.00 | 5,947,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 21,843,000.00 | 27,319,000.00 | 28,531,000.00 | 39,946,000.00 | 45,776,000.00 | ||||||||
| Selling, General & Admin... | 2,055,000.00 | 5,947,000.00 | 8,259,000.00 | 9,817,000.00 | 12,339,000.00 | 14,833,000.00 | 21,843,000.00 | 27,319,000.00 | 28,531,000.00 | 39,946,000.00 | 45,776,000.00 | ||||||||
| Selling & Marketing Exp... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Depreciation and Amortiz... | 19,000.00 | 89,000.00 | 132,000.00 | 249,000.00 | 293,000.00 | 901,000.00 | 1,624,000.00 | 2,001,000.00 | 1,964,000.00 | 964,000.00 | 0.00 | ||||||||
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -5,000.00 | -122,000.00 | -7,000.00 | 113,739,000.00 | 0.00 | ||||||||
| Total Operating Expenses | 8,885,000.00 | 17,400,000.00 | 26,402,000.00 | 32,631,999.00 | 49,058,000.00 | 79,433,000.00 | 81,481,000.00 | 84,388,000.00 | 87,110,000.00 | 243,189,000.00 | 208,566,000.00 | ||||||||
| Cost and Exponses | 8,904,000.00 | 17,400,000.00 | 26,534,000.00 | 32,881,000.00 | 49,351,000.00 | 80,334,000.00 | 81,481,000.00 | 84,388,000.00 | 87,110,000.00 | 243,189,000.00 | 0.00 | ||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-8,904,000.00
+0% |
-11,315,000.00
+27% |
-21,906,000.00
+94% |
-27,676,000.00
+26% |
-45,463,000.00
+64% |
-80,334,000.00
+77% |
-81,481,000.00
+1% |
-65,649,000.00
-19% |
-84,781,000.00
+29% |
-242,303,000.00
+186% |
-208,566,000.00
-14% |
||||||||
| Operating Income Ratio | (0.00%) | (-1.86%) | (-4.73%) | (-5.32%) | (-11.69%) | (0.00%) | (0.00%) | (-3.50%) | (-36.40%) | (-273.48%) | (0.00%) | ||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 1,000.00 | 22,000.00 | 244,000.00 | 482,000.00 | 1,172,000.00 | 2,143,000.00 | 593,000.00 | 111,000.00 | 837,000.00 | 6,147,000.00 | 21,312,000.00 | ||||||||
| Interest Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Total Other Income/Exp... | -1,443,000.00 | 20,000.00 | 208,000.00 | 440,000.00 | 1,115,000.00 | 2,080,000.00 | 588,000.00 | -11,000.00 | 830,000.00 | -96,513,000.00 | 599,000.00 | ||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -10,328,000.00 | -11,226,000.00 | -21,774,000.00 | -27,427,000.00 | -45,170,000.00 | -77,353,000.00 | -79,269,000.00 | -63,659,000.00 | -83,214,000.00 | -127,820,000.00 | -208,566,000.00 | ||||||||
| EBITDA ratio | (0.00%) | (-1.84%) | (-4.70%) | (-5.27%) | (-11.62%) | (0.00%) | (0.00%) | (-3.42%) | (-35.73%) | (-144.27%) | (0.00%) | ||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -10,347,000.00 | -11,295,000.00 | -21,698,000.00 | -27,236,000.00 | -44,348,000.00 | -78,254,000.00 | -80,893,000.00 | -65,660,000.00 | -83,951,000.00 | -338,816,000.00 | -207,967,000.00 | ||||||||
| Income Before Tax Ratio | (0.00%) | (-1.86%) | (-4.69%) | (-5.23%) | (-11.41%) | (0.00%) | (0.00%) | (-3.50%) | (-36.05%) | (-382.41%) | (0.00%) | ||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -593,000.00 | 141,000.00 | -136,000.00 | -26,000.00 | -51,000.00 | ||||||||
| Net Income | |||||||||||||||||||
| Net Income | -10,347,000.00
+0% |
-11,295,000.00
+9% |
-21,698,000.00
+92% |
-27,236,000.00
+26% |
-44,348,000.00
+63% |
-78,254,000.00
+76% |
-80,893,000.00
+3% |
-65,801,000.00
-19% |
-83,815,000.00
+27% |
-338,790,000.00
+304% |
-208,018,000.00
-39% |
||||||||
| Net Income Ratio | (0.00%) | (-1.86%) | (-4.69%) | (-5.23%) | (-11.41%) | (0.00%) | (0.00%) | (-3.51%) | (-35.99%) | (-382.38%) | (0.00%) | ||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -18.91 | -25.20 | -55.40 | -45.01 | -53.25 | -61.23 | -37.89 | -25.02 | -24.86 | -46.15 | -0.56 | ||||||||
| Diluted EPS | -18.91 | -25.20 | -55.40 | -45.01 | -53.25 | -61.23 | -37.89 | -25.02 | -24.86 | -46.15 | -0.56 | ||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 547,193.00 | 457,193.00 | 391,669.00 | 605,127.00 | 832,902.00 | 1,277,985.00 | 2,134,869.00 | 2,629,784.00 | 3,371,231.00 | 7,340,307.00 | 374,387,000.00 | ||||||||
| Diluted Share Outstanding | 547,193.00 | 457,193.00 | 391,669.00 | 605,127.00 | 832,902.00 | 1,277,985.00 | 2,134,869.00 | 2,629,784.00 | 3,371,231.00 | 7,340,307.00 | 374,387,000.00 | ||||||||